• Je něco špatně v tomto záznamu ?

Measurement of protein synthesis: in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H]tyrosine, and 2-fluoro-[ (3)H]tyrosine

S. Eigner, DR. Beckford Vera, M. Fellner, NS. Loktionova, M. Piel, F. Melichar, F. Rösch, TL. Roß, O. Lebeda, KE. Henke,

. 2013 ; 194 () : 269-83.

Jazyk angličtina Země Německo

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024339

AIM: Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. It has been known for more than 40 years that this antibiotic is a universal protein synthesis inhibitor that acts as a structural analog of an aminoacyl-transfer RNA (aa-tRNA) in eukaryotic ribosomes. Due to the role of enzymes and their synthesis in situations of need (DNA damage, e.g., after chemo- or radiation therapy), determination of protein synthesis is important for control of antitumor therapy, to enhance long-term survival of tumor patients, and to minimize side-effects of therapy. Multiple attempts to reach this goal have been made through the last decades, mostly using radiolabeled amino acids, with limited or unsatisfactory success. The aim of this study is to estimate the possibility of determining protein synthesis ratios by using (68)Ga-DOTA-puromycin ((68)Ga-DOTA-Pur), [(3)H]tyrosine, and 2-fluoro-[(3)H]tyrosine and to estimate the possibility of different pathways due to the fluorination of tyrosine. METHODS: DOTA-puromycin was synthesized using a puromycin-tethered controlled-pore glass (CPG) support by the usual protocol for automated DNA and RNA synthesis following our design. (68)Ga was obtained from a (68)Ge/(68)Ga generator as described previously by Zhernosekov et al. (J Nucl Med 48:1741-1748, 2007). The purified eluate was used for labeling of DOTA-puromycin at 95°C for 20 min. [(3)H]Tyrosine and 2-fluoro-[(3)H]tyrosine of the highest purity available were purchased from Moravek (Bera, USA) or Amersham Biosciences (Hammersmith, UK). In vitro uptake and protein incorporation as well as in vitro inhibition experiments using cycloheximide to inhibit protein synthesis were carried out for all three substances in DU145 prostate carcinoma cells (ATCC, USA). (68)Ga-DOTA-Pur was additionally used for μPET imaging of Walker carcinomas and AT1 tumors in rats. Dynamic scans were performed for 45 min after IV application (tail vein) of 20-25 MBq (68)Ga-DOTA-Pur. RESULTS: No significant differences in the behavior of [(3)H]tyrosine and 2-fluoro-[(3)H]tyrosine were observed. Uptake of both tyrosine derivatives was decreased by inhibition of protein synthesis, but only to a level of 45-55% of initial uptake, indicating no direct link between tyrosine uptake and protein synthesis. In contrast, (68)Ga-DOTA-Pur uptake was directly linked to ribosomal activity and, therefore, to protein synthesis. (68)Ga-DOTA-Pur μPET imaging in rats revealed high tumor-to-background ratios and clearly defined regions of interest in the investigated tumors. SUMMARY: Whereas the metabolic pathway of (68)Ga-DOTA-Pur is directly connected with the process of protein synthesis and shows high tumor uptake during μPET imaging, neither [(3)H]tyrosine nor 2-fluoro-[(3)H]tyrosine can be considered useful for determination of protein synthesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024339
003      
CZ-PrNML
005      
20130709105107.0
007      
ta
008      
130703s2013 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/978-3-642-27994-2_14 $2 doi
035    __
$a (PubMed)22918764
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Eigner, Sebastian $u Department of Radiopharmaceuticals, Academic of Sciences of the Czech Republic, Rez, Czech Republic. eigner@ujf.cas.cz
245    10
$a Measurement of protein synthesis: in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H]tyrosine, and 2-fluoro-[ (3)H]tyrosine / $c S. Eigner, DR. Beckford Vera, M. Fellner, NS. Loktionova, M. Piel, F. Melichar, F. Rösch, TL. Roß, O. Lebeda, KE. Henke,
520    9_
$a AIM: Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. It has been known for more than 40 years that this antibiotic is a universal protein synthesis inhibitor that acts as a structural analog of an aminoacyl-transfer RNA (aa-tRNA) in eukaryotic ribosomes. Due to the role of enzymes and their synthesis in situations of need (DNA damage, e.g., after chemo- or radiation therapy), determination of protein synthesis is important for control of antitumor therapy, to enhance long-term survival of tumor patients, and to minimize side-effects of therapy. Multiple attempts to reach this goal have been made through the last decades, mostly using radiolabeled amino acids, with limited or unsatisfactory success. The aim of this study is to estimate the possibility of determining protein synthesis ratios by using (68)Ga-DOTA-puromycin ((68)Ga-DOTA-Pur), [(3)H]tyrosine, and 2-fluoro-[(3)H]tyrosine and to estimate the possibility of different pathways due to the fluorination of tyrosine. METHODS: DOTA-puromycin was synthesized using a puromycin-tethered controlled-pore glass (CPG) support by the usual protocol for automated DNA and RNA synthesis following our design. (68)Ga was obtained from a (68)Ge/(68)Ga generator as described previously by Zhernosekov et al. (J Nucl Med 48:1741-1748, 2007). The purified eluate was used for labeling of DOTA-puromycin at 95°C for 20 min. [(3)H]Tyrosine and 2-fluoro-[(3)H]tyrosine of the highest purity available were purchased from Moravek (Bera, USA) or Amersham Biosciences (Hammersmith, UK). In vitro uptake and protein incorporation as well as in vitro inhibition experiments using cycloheximide to inhibit protein synthesis were carried out for all three substances in DU145 prostate carcinoma cells (ATCC, USA). (68)Ga-DOTA-Pur was additionally used for μPET imaging of Walker carcinomas and AT1 tumors in rats. Dynamic scans were performed for 45 min after IV application (tail vein) of 20-25 MBq (68)Ga-DOTA-Pur. RESULTS: No significant differences in the behavior of [(3)H]tyrosine and 2-fluoro-[(3)H]tyrosine were observed. Uptake of both tyrosine derivatives was decreased by inhibition of protein synthesis, but only to a level of 45-55% of initial uptake, indicating no direct link between tyrosine uptake and protein synthesis. In contrast, (68)Ga-DOTA-Pur uptake was directly linked to ribosomal activity and, therefore, to protein synthesis. (68)Ga-DOTA-Pur μPET imaging in rats revealed high tumor-to-background ratios and clearly defined regions of interest in the investigated tumors. SUMMARY: Whereas the metabolic pathway of (68)Ga-DOTA-Pur is directly connected with the process of protein synthesis and shows high tumor uptake during μPET imaging, neither [(3)H]tyrosine nor 2-fluoro-[(3)H]tyrosine can be considered useful for determination of protein synthesis.
650    _2
$a zvířata $7 D000818
650    _2
$a radioizotopy galia $x diagnostické užití $x izolace a purifikace $7 D005710
650    _2
$a heterocyklické sloučeniny monocyklické $x chemie $7 D006573
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a experimentální nádory $x metabolismus $7 D009374
650    _2
$a pozitronová emisní tomografie $7 D049268
650    12
$a proteosyntéza $x účinky léků $7 D014176
650    _2
$a puromycin $x diagnostické užití $7 D011691
650    _2
$a radiofarmaka $x chemická syntéza $x diagnostické užití $7 D019275
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a tritium $x diagnostické užití $7 D014316
650    _2
$a tyrosin $x metabolismus $7 D014443
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Beckford Vera, Denis R $u -
700    1_
$a Fellner, Marco $u -
700    1_
$a Loktionova, Natalia S $u -
700    1_
$a Piel, Markus $u -
700    1_
$a Melichar, Frantisek $u -
700    1_
$a Rösch, Frank $u -
700    1_
$a Roß, Tobias L $u -
700    1_
$a Lebeda, Ondrej $u -
700    1_
$a Henke, Katerina Eigner $u -
773    0_
$w MED00005233 $t Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer $x 0080-0015 $g Roč. 194(2013), s. 269-83
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22918764 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20130709105529 $b ABA008
999    __
$a ok $b bmc $g 988019 $s 822719
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 194 $d 269-83 $i 0080-0015 $m Recent Results in Cancer Research $n Recent Results Cancer Res $x MED00005233
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...